ARUP Laboratories
-
Two ARUP Medical Directors Receive Career Achievement Awards
Two ARUP Medical Directors Receive Career Achievement Awards
-
ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG
ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG
-
ARUP Creates Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners
ARUP Creates Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners
-
Rarity Bioscience Announces That ARUP Laboratories Has Become the First U.S. Reference Lab To Validate Its Ultrasensitive superRCA Assay
Rarity Bioscience Announces That ARUP Laboratories Has Become the First U.S. Reference Lab To Validate Its Ultrasensitive superRCA…
-
Adam Barker, PhD, Named President and Chief Operations Officer of ARUP Reference Business Unit
A microbiologist, Adam Barker, PhD, was ARUP’s chief scientific officer and director of Research and Development before being…
-
ARUP’s Advanced Practice Laboratory: A National Model for Bridging Education and Industry
September 30, Salt Lake City—In a groundbreaking collaboration between ARUP Laboratories and the University of Utah, the new…
-
ARUP Achieves Reaccreditation Under College of American Pathologists ISO 15189 Program
ARUP Achieves Reaccreditation Under College of American Pathologists ISO 15189 Program
-
ARUP Launches pTau 217 Blood Test To Detect Alzheimer’s Disease Pathology
The biomarker pTau 217 is associated with Alzheimer’s disease pathology and can be detected in plasma, providing a…
-
Tasso and ARUP Laboratories Announce Partnership, Combined Offering for Decentralized Clinical Research Biomarker Testing
The partnership combines Tasso’s clinical grade blood collection solutions, such as the Tasso+ device pictured above, with ARUP’s…
-
ARUP Statement on FDA Final Rule to Regulate Laboratory-Developed Tests as Medical Devices
ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs.
-
Departing Biochemical Geneticist Leaves Legacy of Scientific Discovery and Devoted Patient Care at ARUP, U of U Health
Nicola Longo, MD, PhD, has spent more than 20 years at University of Utah Health and ARUP Laboratories…
-
New ARUP University Business Unit Focuses on Patients and Services at University of Utah Health
Dan Albertson, MD, will serve as president of the University Business Unit.
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
